PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 93 filers reported holding PIERIS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $39,000 | -27.8% | 11,434 | -0.7% | 0.00% | – |
| Q2 2019 | $54,000 | +38.5% | 11,510 | -1.5% | 0.00% | – |
| Q1 2019 | $39,000 | +34.5% | 11,689 | +7.9% | 0.00% | – |
| Q4 2018 | $29,000 | -97.2% | 10,833 | -94.1% | 0.00% | -100.0% |
| Q3 2018 | $1,036,000 | +20.0% | 184,931 | +8.6% | 0.00% | 0.0% |
| Q2 2018 | $863,000 | -32.5% | 170,254 | -9.2% | 0.00% | 0.0% |
| Q1 2018 | $1,278,000 | – | 187,402 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 5,628,585 | $5,853,728 | 5.06% |
| Aquilo Capital Management, LLC | 4,552,876 | $4,734,991 | 1.78% |
| BVF INC/IL | 5,080,320 | $5,283,533 | 0.22% |
| Soleus Capital Management, L.P. | 1,000,000 | $1,040,000 | 0.15% |
| Cutter & CO Brokerage, Inc. | 378,479 | $393,618 | 0.13% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,220,798 | $1,269,630 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 365,047 | $380 | 0.05% |
| Annandale Capital, LLC | 67,000 | $70 | 0.02% |
| WEALTH EFFECTS LLC | 21,700 | $22,568 | 0.01% |
| Sigma Planning Corp | 343,934 | $357,691 | 0.01% |